QbD Considerations for Topical and Transdermal Product Development

Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale

“…QbD has been employed in several studies towards preclinical development of transferosomal formulations (Table 2) (Csanyi, 2018;Gilani, 2019). The first example was the development of zolmitriptan transferosomes for migraine using phosphatidylcholine and Tween ® 80.…”